{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04037",
    "Peptide Name": "LL-37_Ranalexin hybrid peptide (LL-37_Renalexin, LL-37+GS+Ranalexin, synthetic AMPs)",
    "Source": "Hybrid peptide, designed",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESGSFLGGLIKIVPAMICAVTKKC",
    "Sequence Length": 59,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 9,
    "Boman Index": 1.46,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "44%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (62.71%) toLL-37A hybrid peptide consisting of full length LL-37 and ranalexin are connected via a GS linker.Activity: active against S. aureus MRSA (MIC 17.5-20.1 uM), E. coli (MIC 19.7-21.4 uM), and K. pneumoniae (MIC 27.8 uM) bacteria clinical isolates.Recombinant production:bacteria:Escherichia coli: expressed as a fusion with small metal-binding proteins SmbP or CusF3H+.  cleaved with enzyme enterokinase, Purified via immobilized metal affinity chromatography, yield: 0.7-2.1 mg/L after affinity column.",
    "Author": "Narh JK, Casillas-Vega NG, Zarate X. 2024",
    "Reference": "Appl Microbiol Biotechnol. 2024 Dec;108(1):126. doi: 10.1007/s00253-023-12887-5.PubMed",
    "Title": "LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides."
  },
  "3D Structure": []
}